Religious-right legal activist Phillip Jauregui appeared on the American Family Radio’s “At the Core” program with host Walker Wildmon yesterday to complain about the lack of conservative evangelical Supreme Court justices and to tout the Center’s “green list” of potential Republican nominees who meet the Center’s “biblical worldview” standard. Wildmon, the grandson of AFA Founder […]
We need to talk more about Project 2025, the terrifyingly right-wing blueprint crafted by right-wing think tank The Heritage Foundation that is meant to guide the next Republican administration. If you aren't very familiar with Project 2025, it's time to school yourself and start spreading the word. — Read the rest
The Supreme Court heard arguments challenging access to the abortion pill Mifepristone. Rachel Maddow joins Joy Reid to discuss.
Abortion access returns to the high court, nearly two years after the Supreme Court overturned the landmark Roe v. Wade. This time access to the abortion pill mifepristone hangs in the balance.
Earlier this week, the United States Supreme Court dismissed an appeal from the parents of a teenage boy who were stripped of custody rights by the state of Indiana for not affirming their son's self-proclaimed "gender identity” as a girl.
Americans overwhelmingly support mifepristone remaining available. And even merely restricting it could reverberate hugely -- at a time when the GOP would rather ignore such issues.
The justices will hear arguments Tuesday on whether to limit access to a medication used in more than 60 percent of abortions in the United States.
It always seemed farfetched that anti-abortion doctors could argue that they have the right to ask a court to severely restrict a drug approved by the U.S. Food and Drug Administration simply because they don't want to treat women who might experience complications. Do they even have standing to bring this case? Do they have any proof they have been so harmed or injured that it justifies restricting FDA-approved access to mifepristone, the first in a two-drug regimen for medication abortion?...
The Supreme Court will again wade into the fractious issue of abortion this week when it hears arguments over a medication used in the most common way to end a pregnancy, a case with profound implications for millions of women no matter where they live in America and, perhaps, for the race for the White House. Two years after the Supreme Court overturned Roe v. Wade and cleared the way for bans or severe restrictions on abortion in many Republican-led states, abortion opponents on Tuesday will...
Abortion opponents on Tuesday will ask the high court to ratify a ruling from a conservative federal appeals court that would limit access to the medication mifepristone.
The justices’ comments in arguments over FDA actions that eased access to the drug, mifepristone, suggest that
Seven former FDA commissioners said in a court filing that the agency exercised special care in its initial approval of mifepristone because it was dealing with an abortion drug.